390 related articles for article (PubMed ID: 14501955)
1. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
Sheehan M; Wong HR; Hake PW; Zingarelli B
Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats.
Shih CC; Chen SJ; Chen A; Wu JY; Liaw WJ; Wu CC
Crit Care Med; 2008 Jun; 36(6):1864-72. PubMed ID: 18496380
[TBL] [Abstract][Full Text] [Related]
3. The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis.
Wheeler DS; Lahni PM; Hake PW; Denenberg AG; Wong HR; Snead C; Catravas JD; Zingarelli B
Shock; 2007 Sep; 28(3):353-9. PubMed ID: 17545942
[TBL] [Abstract][Full Text] [Related]
4. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats.
Feng X; Yan W; Liu X; Duan M; Zhang X; Xu J
J Surg Res; 2006 Sep; 135(1):129-36. PubMed ID: 16616763
[TBL] [Abstract][Full Text] [Related]
5. Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation.
Kiuchi H; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2009 May; 181(5):2339-48. PubMed ID: 19303104
[TBL] [Abstract][Full Text] [Related]
6. Administration of human protein C improves survival in an experimental model of sepsis.
Messaris E; Betrosian AP; Memos N; Chatzigianni E; Boutsikou M; Economou V; Dontas I; Theodossiades G; Konstadoulakis MM; Douzinas EE
Crit Care Med; 2010 Jan; 38(1):209-16. PubMed ID: 19726977
[TBL] [Abstract][Full Text] [Related]
7. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis.
Feng X; Liu J; Yu M; Zhu S; Xu J
Clin Chim Acta; 2007 Feb; 376(1-2):60-7. PubMed ID: 16942763
[TBL] [Abstract][Full Text] [Related]
8. Influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats.
Feng X; Ren B; Xie W; Huang Z; Liu J; Guan R; Duan M; Xu J
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1081-8. PubMed ID: 16987337
[TBL] [Abstract][Full Text] [Related]
9. Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure.
Schmidt C; Höcherl K; Kurt B; Bucher M
Crit Care Med; 2008 Aug; 36(8):2363-72. PubMed ID: 18596633
[TBL] [Abstract][Full Text] [Related]
10. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.
Bedirli A; Kerem M; Pasaoglu H; Akyurek N; Tezcaner T; Elbeg S; Memis L; Sakrak O
Shock; 2007 Apr; 27(4):397-401. PubMed ID: 17414422
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch 130/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and Toll-like receptors expression in monocytes during sepsis.
Xie J; Lv R; Yu L; Huang W
J Surg Res; 2010 May; 160(1):133-8. PubMed ID: 19766237
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
Hofer S; Eisenbach C; Lukic IK; Schneider L; Bode K; Brueckmann M; Mautner S; Wente MN; Encke J; Werner J; Dalpke AH; Stremmel W; Nawroth PP; Martin E; Krammer PH; Bierhaus A; Weigand MA
Crit Care Med; 2008 Feb; 36(2):404-8. PubMed ID: 18091537
[TBL] [Abstract][Full Text] [Related]
13. Early treatment with hydroxyethyl starch 130/0.4 causes greater inhibition of pulmonary capillary leakage and inflammatory response than treatment instituted later in sepsis induced by cecal ligation and puncture in rats.
Feng X; Hu Y; Ding J; Ge Y; Song J; Ai Q; Zhang Z; Xu J
Ann Clin Lab Sci; 2007; 37(1):49-56. PubMed ID: 17311869
[TBL] [Abstract][Full Text] [Related]
14. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis.
Costello J; Higgins B; Contreras M; Chonghaile MN; Hassett P; O'Toole D; Laffey JG
Crit Care Med; 2009 Aug; 37(8):2412-20. PubMed ID: 19531945
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
Song XM; Li JG; Wang YL; Hu ZF; Zhou Q; Du ZH; Jia BH
Shock; 2008 Oct; 30(4):468-72. PubMed ID: 18391858
[TBL] [Abstract][Full Text] [Related]
18. Effects of dimethyl sulfoxide, pyrrolidine dithiocarbamate, and methylprednisolone on nuclear factor-kappaB and heat shock protein 70 in a rat model of hemorrhagic shock.
Bini R; Olivero G; Trombetta A; Castagna E; Cotogni P
J Trauma; 2008 Apr; 64(4):1048-54. PubMed ID: 18404074
[TBL] [Abstract][Full Text] [Related]
19. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis.
Yu M; Shao D; Liu J; Zhu J; Zhang Z; Xu J
Int Immunopharmacol; 2007 Aug; 7(8):1076-82. PubMed ID: 17570324
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.
Sheehan M; Wong HR; Hake PW; Malhotra V; O'Connor M; Zingarelli B
Mol Pharmacol; 2002 May; 61(5):953-63. PubMed ID: 11961112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
